Home » THE MAXXON REVAC SAFETY SYRINGE ACTIVATION FORCE LAB STUDY COMPLETED AND DESIGN WORK FINALIZED
THE MAXXON REVAC SAFETY SYRINGE ACTIVATION FORCE LAB STUDY COMPLETED AND DESIGN WORK FINALIZED
Maxxon, Inc., a growing medical products designer, manufacturer, and distributor concentrating on innovative Safety-engineered medical devices (SEMDs) that will have a price advantage over many competitors in the SEMDs arena, announces the results of Globe Med Tech's optimum retraction activation force user/lab study for its Maxxon 3 cc Vacuum Operated Retractable Safety Syringe plunger. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-15-2006/0004381280&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May